M
10b5-1 Plan
$ Value
$83K
Shares
22,000
Price
$4
Filed
Oct 10
Insider
Name
Raben David
Title
Chief Medical Officer
CIK
0002034679
Roles
Officer
Transaction Details
Transaction Date
2025-10-09
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
57,497
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025. | 25% of the shares underlying this option vested on July 24, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Filing Info
Raben David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-25 | BCAX | M | $21K |
| 2026-03-25 | BCAX | ▼ | $104K |
| 2026-03-25 | BCAX | M | $0 |
| 2026-03-04 | BCAX | M | $62K |
| 2026-03-04 | BCAX | ▼ | $302K |
| 2026-03-04 | BCAX | M | $0 |
| 2026-03-03 | BCAX | M | $758 |
| 2026-03-03 | BCAX | ▼ | $4K |
| 2026-03-03 | BCAX | M | $0 |
| 2026-02-02 | BCAX | A | $0 |
Other Insiders at BCAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $40.0M | — | 2026-02-26 |
|
Meisner Lara
Chief Legal Officer
|
— | — | 2026-02-02 |
|
Cohlhepp Ryan
President and COO
|
— | $984K | 2026-04-15 |
|
Hyep Ivan
Chief Financial Officer
|
— | $717K | 2026-04-21 |
|
Mazumdar Claire
Chief Executive Officer
|
— | $1.5M | 2026-04-20 |
|
Raben David
Chief Medical Officer
|
— | $410K | 2026-03-25 |